Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Insider Sells $186,519.28 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Joshua Foukas sold 5,732 shares of USANA Health Sciences stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total transaction of $186,519.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

USANA Health Sciences Stock Down 4.4 %

Shares of NYSE:USNA opened at $29.04 on Friday. The company’s fifty day moving average is $32.53 and its two-hundred day moving average is $35.90. USANA Health Sciences, Inc. has a 12-month low of $27.71 and a 12-month high of $50.11. The company has a market cap of $548.91 million, a P/E ratio of 10.26, a price-to-earnings-growth ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. Equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Sidoti lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, DA Davidson cut their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th.

Hedge Funds Weigh In On USANA Health Sciences

Hedge funds have recently modified their holdings of the stock. R Squared Ltd acquired a new position in shares of USANA Health Sciences in the fourth quarter worth $28,000. Safe Harbor Fiduciary LLC acquired a new position in shares of USANA Health Sciences in the third quarter worth $30,000. KBC Group NV increased its stake in shares of USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after acquiring an additional 519 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of USANA Health Sciences in the fourth quarter worth $83,000. Finally, Quantbot Technologies LP acquired a new position in USANA Health Sciences during the fourth quarter worth $132,000. 54.25% of the stock is owned by institutional investors and hedge funds.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.